• LAST PRICE
    4.1800
  • TODAY'S CHANGE (%)
    Trending Down-0.4500 (-9.7192%)
  • Bid / Lots
    4.1600/ 1
  • Ask / Lots
    4.2000/ 1
  • Open / Previous Close
    4.5900 / 4.6300
  • Day Range
    Low 4.1700
    High 4.6400
  • 52 Week Range
    Low 3.9700
    High 13.1500
  • Volume
    389,787
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 4.63
TimeVolumeMRNS
09:32 ET9504.57
09:33 ET514004.555
09:39 ET1004.625
09:42 ET1004.615
09:44 ET1004.6
09:46 ET26484.62
09:48 ET8004.59
09:50 ET3004.61
09:53 ET8344.605
09:55 ET1174.6
09:57 ET10634.6
10:00 ET250004.595
10:02 ET18114.62
10:04 ET484524.6172
10:06 ET20844.55
10:08 ET1004.555
10:09 ET14004.53
10:13 ET22664.51
10:15 ET24754.5
10:20 ET53294.53
10:22 ET4184.535
10:26 ET17874.585
10:27 ET8004.55
10:31 ET134984.54
10:33 ET1004.54
10:36 ET2004.53
10:38 ET1004.52
10:44 ET7004.53
10:45 ET2004.54
10:49 ET3004.535
10:51 ET3004.54
10:54 ET17004.57
10:56 ET1004.575
10:58 ET4754.57
11:00 ET1004.57
11:02 ET3004.57
11:03 ET5004.55
11:12 ET2004.55
11:16 ET17004.57
11:18 ET3004.56
11:20 ET7444.54
11:25 ET4004.57
11:30 ET3004.59
11:32 ET3004.57
11:34 ET2004.57
11:36 ET2004.59
11:38 ET1004.59
11:39 ET6004.58
11:41 ET32944.57
11:45 ET1004.57
11:48 ET4324.56
11:50 ET16004.51
11:52 ET10004.5
11:54 ET24684.5
11:56 ET2004.5
11:57 ET3004.5
12:01 ET10004.5
12:03 ET3954.51
12:08 ET3004.49
12:10 ET55774.47
12:12 ET21514.465
12:14 ET3954.465
12:15 ET132764.41
12:17 ET3004.415
12:19 ET59174.38
12:21 ET74264.39
12:24 ET10004.405
12:26 ET2004.41
12:30 ET3004.41
12:32 ET13004.41
12:33 ET4004.42
12:35 ET10464.4
12:37 ET4084.375
12:44 ET2004.375
12:46 ET31004.375
12:48 ET35084.38
12:51 ET65594.41
12:53 ET2004.415
12:57 ET1004.415
01:00 ET18504.4
01:09 ET12414.38
01:11 ET79284.3875
01:15 ET1004.39
01:22 ET11464.38
01:29 ET10004.35
01:31 ET9004.36
01:33 ET5004.37
01:38 ET1004.365
01:40 ET6004.34
01:42 ET1004.35
01:45 ET2304.37
01:47 ET3004.365
01:49 ET14644.35
01:51 ET17004.34
01:56 ET4004.35
01:58 ET9034.36
02:03 ET2004.36
02:07 ET11004.39
02:09 ET1004.4
02:12 ET9314.38
02:18 ET2004.39
02:20 ET7814.42
02:21 ET9004.4
02:23 ET6004.4
02:25 ET3304.3986
02:27 ET1004.4
02:30 ET6004.38
02:32 ET1004.38
02:34 ET4004.375
02:38 ET25344.38
02:41 ET1004.38
02:43 ET1004.375
02:45 ET11004.37
02:50 ET1004.365
02:52 ET30444.34
02:54 ET1004.34
02:56 ET1004.34
02:57 ET5004.355
02:59 ET8054.35
03:03 ET1004.36
03:08 ET9004.36
03:10 ET27004.33
03:12 ET9004.34
03:14 ET1004.34
03:17 ET1004.35
03:19 ET4004.34
03:21 ET1004.34
03:26 ET8004.33
03:28 ET2004.325
03:30 ET9334.31
03:32 ET16124.3
03:33 ET1004.3
03:35 ET10064.29
03:37 ET5484.2709
03:39 ET1004.27
03:42 ET14544.28
03:44 ET1004.28
03:46 ET5904.26
03:48 ET9004.27
03:50 ET14194.25
03:51 ET22994.24
03:53 ET10684.24
03:55 ET9504.25
03:57 ET20314.225
04:00 ET252504.18
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMRNS
Marinus Pharmaceuticals Inc
221.0M
-9.8x
---
United StatesSCPH
scPharmaceuticals Inc
234.8M
-4.6x
---
United StatesVRCA
Verrica Pharmaceuticals Inc
138.9M
-3.1x
---
United StatesSMTI
Sanara Medtech Inc
293.3M
-37.9x
---
United StatesLQDA
Liquidia Corp
334.1M
-6.6x
---
United StatesOCUL
Ocular Therapeutix Inc
230.3M
-3.8x
---
As of 2022-12-06

Company Information

Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company, which is focused on the development of therapeutics for seizure disorders. The Company's commercial product, ZTALMY (ganaxolone) oral suspension CV for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder in patients two years of age and older. The potential of ganaxolone is also being studied in other rare seizure disorders, including in Phase III trials in tuberous sclerosis complex and refractory status epilepticus. The Company's ganaxolone is a neuroactive steroid gamma-aminobutyric acid type A (GABAA) receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. The Company’s ganaxolone is also being developed in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings.

Contact Information

Headquarters
Three Radnor Corporate Center 100 Matsonford Rd, Suite 304RADNOR, PA, United States 19087
Phone
484-801-4670
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Scott Braunstein
Chief Financial Officer, Treasurer
Steven Pfanstiel
Vice President, General Counsel, Corporate Secretary
Martha Manning
Chief Medical Officer
Joseph Hulihan
Lead Independent Director
Timothy Mayleben

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$221.0M
Revenue (TTM)
$19.8M
Shares Outstanding
47.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.06
EPS
$-0.43
Book Value
$1.45
P/E Ratio
-9.8x
Price/Sales (TTM)
11.1
Price/Cash Flow (TTM)
---
Operating Margin
-558.04%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.